First Page | Document Content | |
---|---|---|
![]() Date: 2013-01-16 03:21:00Type 1 hypersensitivity Leukotriene antagonists Respiratory therapy Respiratory diseases Allergic rhinitis Montelukast Allergy Atopy Asthma Medicine Health Allergology | Source URL: www.hkjpaed.orgDownload Document from Source WebsiteFile Size: 50,28 KBShare Document on Facebook |
![]() | Leukotriene Modifiers (Accolate®, Singulair®, Zileuton®) What are They?DocID: 19NXJ - View Document |
![]() | Case study: Leukotriene receptor antagonists in primary care at steps 2 and 3 of the national asthma guidelines Importance to NHS Around 5.4 million people in the UK are currently receiving treatment for asthma and the NDocID: 177Pa - View Document |
![]() | Table 2: Asthma Classification of Subjects and Medication Use Subject Lowest Daily Medication Required for Asthma Control Asthma ClassificationDocID: 15dYJ - View Document |
![]() | Int J Biol Med Res.2015;6(1):Int J Biol Med Res www.biomedscidirect.com Volume 3, Issue 1, Jan 2012DocID: 1385d - View Document |
![]() | Dr Shabna Rajapaksa Consultant Paediatrician Ballarat Paediatric Clinic & Ballarat Health Services April 2013DocID: 11wNn - View Document |